By Super Admin

Seeking Alpha / Seaking Alpha - 4 hours ago

YPF Sociedad Anónima Announces Early Participation Date Results with respect to its Offer to Exchange up to U.S.$500,000,000 Aggregate Principal Amount of its 8.500% Senior Notes due July 2025 for the applicable amount of 8.750% Senior Notes due 2031

BUENOS AIRES, Argentina, Sept. 19, 2024 /PRNewswire/ -- YPF S.A. ("YPF" or the "Company" or "us" or "we") today announced the early tender results as of 5:00 p.m. (New York City time) on September 18, 2024 (the "Early Participation Date") of its previously announced offer to exchange (the...

Seeking Alpha / Seaking Alpha - 4 hours ago

Ryvu Therapeutics Announces Dosing of the First Patient in the REMARK Phase II Study of RVU120 for the Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS)

Ryvu Therapeutics has announced the dosing of the first patient in the REMARK Phase II study of RVU120. The primary goal of the REMARK study is to evaluate the safety and efficacy of RVU120 in patients with lower-risk myelodysplastic syndromes (MDS). The study is conducted as an...